CD147 expression as a clinicopathological and prognostic indicator in breast cancer: a meta-analysis and bioinformatics analysis

Abstract Background CD147 belongs to the immunoglobulin superfamily, also known as Basigin (BSG), and is a highly glycosylated single transmembrane glycoprotein present in various tissues. Meta and bioinformatic analyses were used to explore the correlation between CD147 expression and the clinicopa...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuai Shi, Hong-Yan Ma, Yin-zhou Sang, Ying-bo Ju, Xing-guang Wang, Zhi-Gang Zhang
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-024-13202-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846158472145534976
author Shuai Shi
Hong-Yan Ma
Yin-zhou Sang
Ying-bo Ju
Xing-guang Wang
Zhi-Gang Zhang
author_facet Shuai Shi
Hong-Yan Ma
Yin-zhou Sang
Ying-bo Ju
Xing-guang Wang
Zhi-Gang Zhang
author_sort Shuai Shi
collection DOAJ
description Abstract Background CD147 belongs to the immunoglobulin superfamily, also known as Basigin (BSG), and is a highly glycosylated single transmembrane glycoprotein present in various tissues. Meta and bioinformatic analyses were used to explore the correlation between CD147 expression and the clinicopathological characteristics prognosis of breast cancer. Method Literature related to breast cancer was retrieved through PubMed and CNKI databases, and a meta-analysis was conducted using Review Manager 5.2 software. Results The meta-analysis revealed that all articles included data on 522 patients with breast cancer and 492 normal tissues. CD147 expression in breast cancer tissue was higher compared to that in normal tissue([8.92–139.52]; p < 0.00001 I2 = 80%) and negatively correlated with LM, clinical stage, histological grade, and ER positive expression. Bioinformatic analysis revealed that the expression of CD147 in breast cancer tissue was higher than that in normal tissue, and its high expression was closely related to the clinicopathological characteristics of patients, such as LM, histological grading, and clinical staging. According to the TIMER database, CD147 expression was closely related to immune cell infiltration in breast cancer. Conclusion These results indicated that high CD147 expression might be closely linked to the occurrence as well as the development of breast cancer, and can function as a good indicator of prognosis in the future, providing new methods and ideas for the prevention and treatment of breast cancer.
format Article
id doaj-art-a7b8ab3ee3e4448f95d2131d7384d0bf
institution Kabale University
issn 1471-2407
language English
publishDate 2024-11-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj-art-a7b8ab3ee3e4448f95d2131d7384d0bf2024-11-24T12:30:03ZengBMCBMC Cancer1471-24072024-11-0124111110.1186/s12885-024-13202-9CD147 expression as a clinicopathological and prognostic indicator in breast cancer: a meta-analysis and bioinformatics analysisShuai Shi0Hong-Yan Ma1Yin-zhou Sang2Ying-bo Ju3Xing-guang Wang4Zhi-Gang Zhang5Department of Pathology, Cangzhou People’s HospitalDepartment of Pathology, Cangzhou People’s HospitalDepartment of Pathology, Cangzhou People’s HospitalDepartment of Pathology, Cangzhou People’s HospitalDepartment of Pathology, Cangzhou People’s HospitalDepartment of Pathology, Cangzhou People’s HospitalAbstract Background CD147 belongs to the immunoglobulin superfamily, also known as Basigin (BSG), and is a highly glycosylated single transmembrane glycoprotein present in various tissues. Meta and bioinformatic analyses were used to explore the correlation between CD147 expression and the clinicopathological characteristics prognosis of breast cancer. Method Literature related to breast cancer was retrieved through PubMed and CNKI databases, and a meta-analysis was conducted using Review Manager 5.2 software. Results The meta-analysis revealed that all articles included data on 522 patients with breast cancer and 492 normal tissues. CD147 expression in breast cancer tissue was higher compared to that in normal tissue([8.92–139.52]; p < 0.00001 I2 = 80%) and negatively correlated with LM, clinical stage, histological grade, and ER positive expression. Bioinformatic analysis revealed that the expression of CD147 in breast cancer tissue was higher than that in normal tissue, and its high expression was closely related to the clinicopathological characteristics of patients, such as LM, histological grading, and clinical staging. According to the TIMER database, CD147 expression was closely related to immune cell infiltration in breast cancer. Conclusion These results indicated that high CD147 expression might be closely linked to the occurrence as well as the development of breast cancer, and can function as a good indicator of prognosis in the future, providing new methods and ideas for the prevention and treatment of breast cancer.https://doi.org/10.1186/s12885-024-13202-9CD147Breast cancerPrognosticMeta analysisBioinformatic analysis
spellingShingle Shuai Shi
Hong-Yan Ma
Yin-zhou Sang
Ying-bo Ju
Xing-guang Wang
Zhi-Gang Zhang
CD147 expression as a clinicopathological and prognostic indicator in breast cancer: a meta-analysis and bioinformatics analysis
BMC Cancer
CD147
Breast cancer
Prognostic
Meta analysis
Bioinformatic analysis
title CD147 expression as a clinicopathological and prognostic indicator in breast cancer: a meta-analysis and bioinformatics analysis
title_full CD147 expression as a clinicopathological and prognostic indicator in breast cancer: a meta-analysis and bioinformatics analysis
title_fullStr CD147 expression as a clinicopathological and prognostic indicator in breast cancer: a meta-analysis and bioinformatics analysis
title_full_unstemmed CD147 expression as a clinicopathological and prognostic indicator in breast cancer: a meta-analysis and bioinformatics analysis
title_short CD147 expression as a clinicopathological and prognostic indicator in breast cancer: a meta-analysis and bioinformatics analysis
title_sort cd147 expression as a clinicopathological and prognostic indicator in breast cancer a meta analysis and bioinformatics analysis
topic CD147
Breast cancer
Prognostic
Meta analysis
Bioinformatic analysis
url https://doi.org/10.1186/s12885-024-13202-9
work_keys_str_mv AT shuaishi cd147expressionasaclinicopathologicalandprognosticindicatorinbreastcancerametaanalysisandbioinformaticsanalysis
AT hongyanma cd147expressionasaclinicopathologicalandprognosticindicatorinbreastcancerametaanalysisandbioinformaticsanalysis
AT yinzhousang cd147expressionasaclinicopathologicalandprognosticindicatorinbreastcancerametaanalysisandbioinformaticsanalysis
AT yingboju cd147expressionasaclinicopathologicalandprognosticindicatorinbreastcancerametaanalysisandbioinformaticsanalysis
AT xingguangwang cd147expressionasaclinicopathologicalandprognosticindicatorinbreastcancerametaanalysisandbioinformaticsanalysis
AT zhigangzhang cd147expressionasaclinicopathologicalandprognosticindicatorinbreastcancerametaanalysisandbioinformaticsanalysis